Bicara Therapeutics Inc. · NASDAQ:BCAX

Cohlhepp Ryan sold 17,500 Bicara Therapeutics Inc. shares (Form 4)

Traded Sep 8, 2026 · Filed Sep 10, 2026

On Sep 8, 2026, Cohlhepp Ryan (Director, President, COO & Interim CEO) sold 17,500 Bicara Therapeutics Inc. shares at an average US$22.90 for US$401K under a trading plan, leaving 181,641 shares. Filed Sep 10, 2026 (Form 4).

Sold: 17,500 shares
Price: US$22.90 average (US$22.77 to US$23.43)
Value: US$401K
Holding after: 181,641 shares
Trading plan: Yes (Made under a plan set in advance)
Role: Director, President, COO & Interim CEO

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Sep 8, 2026	Common Stock	Option exercise	17,500	US$3.79	199,141	Direct
Sep 8, 2026	Common Stock	Sale	14,058	US$22.77	185,083	Direct
Sep 8, 2026	Common Stock	Sale	3,442	US$23.43	181,641	Direct

Source

View original at SEC

Related